These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30885950)

  • 1. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes.
    Pilemann-Lyberg S; Hansen TW; Persson F; Theilade S; Singh Ahluwalia T; Frystyk J; Rossing P
    Nephrol Dial Transplant; 2019 Apr; 34(4):659-666. PubMed ID: 29660007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S; Rasmussen DGK; Hansen TW; Tofte N; Winther SA; Holm Nielsen S; Theilade S; Karsdal MA; Genovese F; Rossing P
    Diabetes Care; 2019 Sep; 42(9):1760-1768. PubMed ID: 31262950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid and progression of diabetic nephropathy in type 1 diabetes.
    Pilemann-Lyberg S; Lindhardt M; Persson F; Andersen S; Rossing P
    J Diabetes Complications; 2018 May; 32(5):470-473. PubMed ID: 29534864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria.
    Ihara K; Skupien J; Kobayashi H; Md Dom ZI; Wilson JM; O'Neil K; Badger HS; Bowsman LM; Satake E; Breyer MD; Duffin KL; Krolewski AS
    Diabetes Care; 2020 Nov; 43(11):2760-2767. PubMed ID: 32887710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.
    Rotbain Curovic V; Hansen TW; Eickhoff MK; von Scholten BJ; Reinhard H; Jacobsen PK; Persson F; Parving HH; Rossing P
    Acta Diabetol; 2018 Nov; 55(11):1143-1150. PubMed ID: 30105469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus.
    Tougaard NH; Theilade S; Winther SA; Tofte N; Ahluwalia TS; Hansen TW; Rossing P; Frimodt-Møller M
    J Am Heart Assoc; 2020 Oct; 9(19):e017165. PubMed ID: 32955366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
    Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
    Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes.
    Adeshara K; Gordin D; Antikainen AA; Harjutsalo V; Sandholm N; Lehto MJ; Groop PH;
    Cardiovasc Diabetol; 2024 Jul; 23(1):235. PubMed ID: 38965604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes.
    Limonte CP; Valo E; Montemayor D; Afshinnia F; Ahluwalia TS; Costacou T; Darshi M; Forsblom C; Hoofnagle AN; Groop PH; Miller RG; Orchard TJ; Pennathur S; Rossing P; Sandholm N; Snell-Bergeon JK; Ye H; Zhang J; Natarajan L; de Boer IH; Sharma K
    Am J Nephrol; 2020; 51(10):839-848. PubMed ID: 33053547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
    Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
    Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus.
    Colombo M; McGurnaghan SJ; Bell S; MacKenzie F; Patrick AW; Petrie JR; McKnight JA; MacRury S; Traynor J; Metcalfe W; McKeigue PM; Colhoun HM;
    Diabetologia; 2020 Mar; 63(3):636-647. PubMed ID: 31807796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.